STOCK TITAN
  1. Home
  2. News
  3. ZY

Zymergen to Participate in the BofA Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference held in Las Vegas, NV.

Zymergen’s management is scheduled to present on Tuesday, May 10th at 10:55 a.m. Pacific Time / 1:55 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.

About Zymergen
Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets.  We partner with nature to make better products, a better way, for a better world.

Investor Contact
investors@zymergen.com



Stock ZY logo
Zymergen Inc

NASDAQ:ZY

ZY Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

ZY Latest News

Oct 19, 2022
Ginkgo Bioworks Completes Acquisition of Zymergen
Jul 25, 2022
Ginkgo to Acquire Zymergen
Jul 14, 2022
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
Jun 28, 2022
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
May 26, 2022
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

ZY Stock Data

Other Chemical and Fertilizer Mineral Mining
Mining, Quarrying, and Oil and Gas Extraction
Link
United States
Emeryville

About ZY

Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to create, develop and manufacture breakthrough products and materials across a broad range of industries.